The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
Newsletter Nov 2016
Latest Newsletter with interview with EDCTP High-Representatives dr Leonardo Simão and Prof. Marcel Tanner
We published an updated concise version of the Strategic Business Plan 2014-2024 with priorities per disease area.
World AIDS day 2016: EDCTP’s strategy for funding research on HIV
According to the AIDS by numbers 2016 report from UNAIDS, huge progress has been made in the fight against HIV…
Stakeholder meeting reports published: diarrhoeal diseases and lower respiratory tract infections
EDCTP published two reports of the stakeholder meetings on diarrhoeal diseases and lower respiratory tract infections, respectively. The meetings for…